KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Non Operating Income: 2015-2025

Historic Non Operating Income for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $1.0 million.

  • Medpace Holdings' Non Operating Income fell 84.19% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year decrease of 52.77%. This contributed to the annual value of $29.1 million for FY2024, which is 2641.73% up from last year.
  • Medpace Holdings' Non Operating Income amounted to $1.0 million in Q3 2025, which was up 135.76% from -$2.9 million recorded in Q2 2025.
  • Medpace Holdings' Non Operating Income's 5-year high stood at $8.7 million during Q1 2024, with a 5-year trough of -$2.9 million in Q2 2025.
  • Its 3-year average for Non Operating Income is $2.9 million, with a median of $3.4 million in 2023.
  • Per our database at Business Quant, Medpace Holdings' Non Operating Income crashed by 279.89% in 2022 and then surged by 1,168.27% in 2024.
  • Over the past 5 years, Medpace Holdings' Non Operating Income (Quarterly) stood at $1.1 million in 2021, then plummeted by 279.89% to -$2.0 million in 2022, then soared by 272.89% to $3.4 million in 2023, then soared by 151.08% to $8.5 million in 2024, then tumbled by 84.19% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, -$2.9 million for Q2 2025, and $4.6 million during Q1 2025.